(0.12%) 5 112.50 points
(-0.07%) 38 698 points
(0.55%) 17 703 points
(-0.72%) $82.76
(-0.33%) $1.806
(-0.59%) $2 328.20
(-0.81%) $27.14
(-0.23%) $920.70
(0.16%) $0.936
(0.68%) $10.98
(0.10%) $0.804
(-0.82%) $92.42
-1.23% KRW 72 300
Live Chart Being Loaded With Signals
Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally...
Stats | |
---|---|
Today's Volume | 332 520 |
Average Volume | 502 031 |
Market Cap | 5 314.87B |
EPS | KRW0 ( 2024-04-23 ) |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW115.33 (0.16%) |
Volume Correlation
Yuhan Corporation Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Yuhan Corporation Correlation - Currency/Commodity
Yuhan Corporation Financials
Annual | 2023 |
Revenue: | KRW1 858.98B |
Gross Profit: | KRW595.83B (32.05 %) |
EPS: | KRW1 815.36 |
Q4 | 2023 |
Revenue: | KRW437.15B |
Gross Profit: | KRW437.15B (100.00 %) |
EPS: | KRW1 235.13 |
Q3 | 2023 |
Revenue: | KRW483.06B |
Gross Profit: | KRW144.49B (29.91 %) |
EPS: | KRW278.82 |
Q2 | 2023 |
Revenue: | KRW495.72B |
Gross Profit: | KRW152.82B (30.83 %) |
EPS: | KRW115.74 |
Financial Reports:
No articles found.
Yuhan Corporation
Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal injury; ETC products in the areas of cardiovascular, alimentary, genito-urinary, metabolic, respiratory and allergy, and neuro systems; anti-infective, anti-cancer, and hormone and other products; and analgesics, anti-rheumatics, and anesthetics. It also offers OTC products, including vitamins and minerals, hepatopathy drugs and tonics, respiratory system drugs, alimentary system drugs, dermatology and analgesics drugs, and others; and household and healthcare products, such as bleaches, detergents, pesticides, and oral care products. In addition, the company engages in dental business and offers implants, dental equipment/consumable, and dental care products. Additionally, the company manufactures and sells medical supplies for livestock, aquatic animals, and household pets. Further, it provides contract manufacturing services. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators